DUBLIN, Nov. 24, 2021 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that management will participate in
a fireside chat at the fourth annual Evercore ISI HealthCONx
Conference on Thursday, Dec. 2, 2021
at 10:30 a.m. ET (3:30 p.m. GMT). The presentation may be accessed
under the Investors tab on www.alkermes.com and will be
archived for 14 days.
About Alkermes plc
Alkermes plc is a fully-integrated, global
biopharmaceutical company developing innovative medicines in the
fields of neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on addiction, schizophrenia
and bipolar I disorder, and a pipeline of product candidates in
development for neurodegenerative disorders and cancer.
Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research
and manufacturing facility in Athlone, Ireland; and a
manufacturing facility in Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg